Literature DB >> 7565037

[Treatment of motor fluctuations in Parkinson's disease with subcutaneous injections of apomorphine].

M Merello1, R Leiguarda.   

Abstract

Sixteen patients with Parkinson's disease and severe motor fluctuations were treated with subcutaneous injections of apomorphine and followed up prospectively for a year. The use of the drug improved the number of daily "off" hours by 52%, while treatment efficacy remained constant for a year without the appearance of tolerance (ANOVA with repeated measurements:p = 0.0002). No severe adverse effect or any justifying treatment discontinuance were recorded. Apomorphine proved a safe and reliable drug for the treatment of motor fluctuations.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7565037

Source DB:  PubMed          Journal:  Medicina (B Aires)        ISSN: 0025-7680            Impact factor:   0.653


  3 in total

1.  [Intermittent apomorphine injections as rescue therapy for advanced Parkinson's disease. Consensus statement].

Authors:  C Trenkwalder; S Boesch; A Ceballos-Baumann; D Dressler; K Eggert; T Gasser; H Honig; T Müller; H Reichmann; J P Sieb; A Storch; P Odin; W Poewe
Journal:  Nervenarzt       Date:  2008-04       Impact factor: 1.214

Review 2.  [Apomorphine in the treatment of Parkinson's Disease].

Authors:  D Dressler
Journal:  Nervenarzt       Date:  2005-06       Impact factor: 1.214

Review 3.  Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Authors:  Dirk Deleu; Yolande Hanssens; Margaret G Northway
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.